News in Numbers

Amidst declining Covid-19 revenues, Pfizer has started a cost-saving initiative, which is expected to save the company around $1.5bn by 2027.

Marengo Therapeutics is set to receive up to $1.2bn after France-headquartered Ipsen extended its T cell research partnership with the company.

GSK shares fell by over 9% after a Delaware judge ruled that over 70,000 lawsuits alleging its discontinued drug Zantac causes cancer could go ahead.

In the British pharmaceutical industry, 19 M&A deals announced in Q1 2024, worth a total value of $1.1bn, a 32% decline on Q1 2023, as per GlobalData.

According to the Inter Agency Standing Committee (IASC), as conflict in Sudan enters its second year, 18 million people are acutely hungry, including 3.6 million children who are acutely malnourished.